More than 100 participants attended the 21st Annual Norwegian Symposium on Heart Research, hosted by NORHEART in collaboration with ProCardio and the Department of Cardiology, Oslo University Hospital.
The annual symposium was held at Holmenkollen Park Hotel in Oslo on August 31st and September 1st, covering the latest news in cardiac research. Invited lecturers represented the impressive field of cardiovascular research in Norway.
During the successful symposium, 39 rapid fire research abstracts were presented by PhD students and early career researchers. A panel of experienced researchers awarded one winner in each abstract category:
Biomarkers and imaging:
Nasir Saeed, University of Bergen: “High-sensivity cardiac troponins and sex-differences in prognostic value for cardiovascular events and all-cause mortality.”
Inflammation and remodeling:
Chloe Rixon, University of Oslo: “Remodeling cardiac fibrosis in hypertrophic cardiomyopathy by reducing the extracellular matrix protein lumican.”
Cardiac function:
Lars-Egil Hammersbøen, University of Oslo: “Non-invasive pressure-volume analysis by three-dimensional echocardiography: a novel method for left ventricular stroke work and efficiency estimation.”
Genetics and arrhythmias:
Anna Bergan Dahl, University of Oslo: “Local CaMKIIδ movement mediates RyR phosphorylation”
Exercise and prevention:
Kristian Berge, University of Oslo: “Predictors of coronary atherosclerosis in middle-aged and older endurance athletes.”
Abstract prize winners at the 21st Annual Norwegian Symposium on Heart Research. From the left: Lars-Egil Hammersbøen, Kristian Berge, Chloe Rixon, Nasir Saeed and Anna Bergan Dahl. Flanked by director of NORHEART, Professor Kåre-Olav Stensløkken, and Professor Thor Edvardsen.
The session “New therapeutic strategies” was chaired by Kåre-Olav Stensløkken and Nina E. Hasselberg.
Nina E. Hasselberg: “Mavacamten: Targeted therapeutics in cardiomyopathies – finally a breakthrough?”
Bente Halvorsen: “Cardiovascular risk beyond traditional biomarkers – where inflammation and lipids meet”
The session “Challenges in exercise and arrhythmias” was chaired by Henrik Schirmer and Mathis K. Stokke. Stokke also gave the first talk of the session: “Exercise in arrhythmia syndromes – experiences from translational research”
Biomarkers and imaging: Nasir Saeed, University of Bergen: “High-sensivity cardiac troponins and sex-differences in prognostic value for cardiovascular events and all-cause mortality.”
Inflammation and remodeling: Chloe Rixon, University of Oslo: “Remodeling cardiac fibrosis in hypertrophic cardiomyopathy by reducing the extracellular matrix protein lumican.”
Genetics and arrhythmias: Anna Bergan Dahl, University of Oslo: “Local CaMKIIδ movement mediates RyR phosphorylation”
Genetics and arrhythmias: Anna Bergan Dahl, University of Oslo: “Local CaMKIIδ movement mediates RyR phosphorylation”
- priority at NORHEART events
- visibility to other cardiovascular researchers
- e-mail updates and Newsletter
- membership free of charge
Join the Friends of NORHEART mailing list if you want to receive our newsletter without membership.
More than 100 participants attended the 21st Annual Norwegian Symposium on Heart Research, hosted by…
The Norwegian Health Association has awarded the prestigious 2023 Heart Research Award (Hjerteforskningsprisen) to professor Dan…
23 students completed NORHEART’s Introductory Course to Cardiovascular Research and Medicine in Oslo 17–21 October. As usual,…
The 20th Annual Norwegian Symposium on Heart Research was arranged by NORHEART and the Department…